Home Cart Sign in  
Chemical Structure| 14197-60-5 Chemical Structure| 14197-60-5

Structure of 20(S)-Ginsenoside Rg3
CAS No.: 14197-60-5

Chemical Structure| 14197-60-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ginsenoside Rg3 is a steroid glycoside derivative which affects endothelium relaxation in the aorta.

Synonyms: S-ginsenoside Rg3; Ginsenoside Rg3; VN10040

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 20(S)-Ginsenoside Rg3

CAS No. :14197-60-5
Formula : C42H72O13
M.W : 785.01
SMILES Code : O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@@H]3C(C)([C@]4([C@@](C)([C@@]5([H])C[C@@H](O)[C@@]([C@H](CC6)[C@@](CC/C=C(C)\C)(C)O)([H])[C@]6(C)[C@]5(C)CC4)CC3)[H])C)CO)O)O)CO)O)O
Synonyms :
S-ginsenoside Rg3; Ginsenoside Rg3; VN10040
MDL No. :MFCD06410950
InChI Key :RWXIFXNRCLMQCD-JBVRGBGGSA-N
Pubchem ID :9918693

Safety of 20(S)-Ginsenoside Rg3

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
primary cardiac fibroblasts (CFs) 5, 10, 20 μM 48 h To investigate the inhibitory effect of Rg3 on TGF-β1-induced CFs proliferation, results showed that Rg3 dose-dependently inhibited CFs proliferation. J Ginseng Res. 2023 Nov;47(6):743-754

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice LAD coronary artery ligation-induced MI model Intragastric administration 20 mg/kg, 40 mg/kg Once daily for 4 weeks To investigate the protective effect of Rg3 on myocardial fibrosis and cardiac function, results showed that Rg3 dose-dependently improved cardiac function and inhibited collagen deposition. J Ginseng Res. 2023 Nov;47(6):743-754
Wistar rats Alcohol GU model, pylorus-ligated GU model, acetic acid GU model Intragastric administration 20 mg/kg Once daily for 7 days To evaluate the treatment efficacy of 20(S)-ginsenoside Rg3 on gastric ulcer. The results showed that 20(S)-ginsenoside Rg3 significantly decreased the UI scores and UI ratios in all three GU models, and demonstrated antiulcer effects by decreasing ET-1 and NOS2 levels and increasing NO, superoxide dismutase, EGF, and epidermal growth factor receptor levels. In addition, high-dose 20(S)-ginsenoside Rg3 showed satisfactory gastric mucosa protection effects. J Ginseng Res. 2019 Oct;43(4):550-561
BALB/c mice Lethal HVJ infection model Oral 1 mg/mouse Once daily for 3, 2, and 1 day before infection 20(S)-Ginsenoside Rg3 showed partial protection against HVJ infection J Ginseng Res. 2013 Mar;37(1):80-6

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.27mL

0.25mL

0.13mL

6.37mL

1.27mL

0.64mL

12.74mL

2.55mL

1.27mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories